In partnership with

Anna's Daybreak News

_{Just facts, you think for yourself}

Friday, 5:19 AM

October 31, 2025

Good morning news friend! Discover today’s defining stories and the future they set in motion. 📰🌟

Notice: If you’re reading this email in the Gmail app, you will not be able to see both of our health articles at the bottom. 👉 Click here to view the full newsletter online — it’s free and easy to read.

What Wall Street Insiders Are Actually Doing (It's Not What You're Reading in the News)

Are you trading on headlines? You might be missing the real signals.

This week's insider report shows patterns the crowd will likely get wrong.

For example, those "bearish" CEO sales at Transocean? We explain why they're just noise.

The real story is what's not happening. At Alphabet, the CEO and CAO just stopped selling millions right after strong earnings. At AT&T, the CEO's personal stake just jumped by over 1100%.

These are the actions that matter.

This brief gives you the context behind the filings. We also look at the big ownership reductions at Meta, Amazon, and Tesla and explain what's really going on.

Stop guessing based on headlines. Get the analysis Now.

Prince Andrew No More

King Charles III stripped Prince Andrew of all royal titles, including Duke of York and Prince, citing his ties to Jeffrey Epstein and allegations of sexual abuse by Virginia Giuffre, who died by suicide in 2025.

Andrew denies the claims. He was evicted from Royal Lodge and moved to a private home on Sandringham Estate, losing use of “His Royal Highness” and membership in the Order of the Garter. Andrew remains eighth in line to the throne; his daughters keep their titles.

The king will provide private financial support, while Andrew’s ex-wife loses family backing. The move aims to protect the monarchy’s reputation amid declining public support and increased scrutiny.

Sources: AP News, Bloomberg, WallStreetJournal, NYTimes, Reuters. 

Airstrikes on Venezuelan Military

The Trump administration is considering airstrikes on Venezuelan military sites involved in drug smuggling, targeting airstrips, ports, and naval facilities. Since September 2025, the U.S. has launched 15 strikes on drug vessels, killing over 60.

The CIA is authorized to act in Venezuela against drug trafficking and to facilitate prisoner release. Venezuelan gang Tren de Aragua, linked to Maduro's circle, is designated a terrorist group. Venezuela serves as a transit route for Colombian cocaine; some officials face U.S. indictments.

The U.S. has increased military presence near Venezuela, with bomber flights testing defenses. Maduro’s regime controls Russian-made air defenses. Experts warn strikes could strengthen Maduro or prompt leadership attacks next.

Sources: Com, Bnonews, WallStreetJournal, Bloomberg.

Trump Urges Senate to Scrap Filibuster

President Trump urged Senate Republicans to end the filibuster to pass funding and end the government shutdown now in its 30th day. Republicans hold 53 seats but need seven Democratic votes, blocked by disputes over Affordable Care Act tax credits.

Senate leaders largely oppose scrapping the filibuster, doubting they have the votes to do so. The shutdown, starting October 1, affects 750,000 federal workers and may cost the U.S. economy $7 billion to $14 billion in Q4, reducing GDP by up to 2%. Americans face rising food insecurity, heating costs, and travel delays.

Bipartisan talks continue but no resolution is expected before SNAP funding expires in early November.

Sources: AP News, CNBC, Cbsnews, AXIOS.

Did you know we also write in-depth deep dives? They are long, packed with insights, and have received rave reviews. If you’re up for a detailed, action-packed read, check them out:

• Social Security Squeeze

• The Widowhood Penalty

• The Asset Protection Blueprint

• The Retirement Tax Bomb

• Inflammation Crisis

• The Gut Brain Axis

Silicon Valley’s $400 Billion AI Investment

Silicon Valley’s top tech firms plan to invest $400 billion in AI in 2025 amid persistent supply shortages of computing power. Meta nearly doubled its capital expenditures to $72 billion in 2024, with more growth expected, but its shares dropped 11% over unclear returns.

Microsoft aims to double its data centers in two years but faces capacity constraints limiting Azure revenue; shares fell nearly 3%. Amazon rapidly expands cloud capacity, boosting shares 10%. Google raises spending from $85 billion to $91–93 billion, generating billions in AI revenue; shares rose 6%.

Alphabet’s spending is most efficient, at 49% of cash flow versus 64.6% (Meta) and 77.5% (Microsoft). Investors remain cautious about AI’s uncertain returns and potential bubble.

Sources: AP News, AP News, AP News, Techbrew, WallStreetJournal, Reuters.

Triple-Drug Therapy Completely Eliminates Leukemia

Researchers developed a triple-drug immunotherapy that eradicates leukemia in preclinical animal models by inducing necroptosis, a form of cell death that activates immune responses.

Malignant B cells lack MLKL protein, preventing necroptosis; the drug combination restores this pathway. The therapy triggers strong immune activation, confirmed by real-time imaging of immune cells attacking cancer. This approach aims to convert tumor cells into immune stimulators.

The findings suggest potential applications in B cell leukemias and lymphomas, offering a new direction in cancer immunotherapy by leveraging the body’s own defenses to prevent relapse. The study was published in Science Advances in August 2025.

Sources: SciTechDaily, Medicalxpress.

Parkinson’s Hidden Brain Pulses

Researchers identified brain signal patterns in Parkinson’s patients’ basal ganglia linked to symptom severity, enabling real-time tailored deep brain stimulation.

Separately, a new 7 Tesla MRI technique revealed microvascular pulsations in deep white matter increase with age and blood pressure, potentially disrupting brain waste clearance and accelerating Alzheimer’s.

The Parkinson’s study involved 119 patients, focusing on beta waves and spike signals across brain hemispheres. The Alzheimer’s research tracked microvascular volumetric pulsatility as a biomarker for early vascular changes tied to dementia risk.

These findings offer noninvasive methods to monitor neurodegenerative disease progression and personalize treatments by targeting hidden electrical and vascular brain pulses.

Sources: Sciencealert, SciTechDaily.

“A man who thinks he can be great all by himself is like a fella trying to row a boat with only one oar—he'll do a powerful lot of spinning, but he ain't liable to get anywhere important.”

Baked with love,

Anna Eisenberg ❤️